CBHD.DE实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 23:35):

Stats
今日成交量	77.00
平均成交量	478.00
市值	23.94B
EPS	€0 ( 2023-09-30 )
Last Dividend	€5.00 ( 2023-05-15 )
Next Dividend	€0 ( N/A )
P/E	38.75
ATR14	€0 (0.00%)

Coloplast A/S 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Coloplast A/S 财务报表

Annual	2023
营收:	€24.50B
毛利润:	€16.33B (66.64 %)
EPS:	€22.21

FY	2023
营收:	€24.50B
毛利润:	€16.33B (66.64 %)
EPS:	€22.21

FY	2022
营收:	€22.58B
毛利润:	€15.53B (68.78 %)
EPS:	€22.14

FY	2021
营收:	€19.43B
毛利润:	€13.31B (68.53 %)
EPS:	€22.70

Financial Reports:

No articles found.

Coloplast A/S Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
€0 (N/A)	€15.00 (N/A)	€0 (N/A)	€5.00 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)

Coloplast A/S Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 8.24 - good (82.42%) | Divividend Growth Potential Score: 3.98 - Decrease likely (20.36%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	€1.800	2007-12-19
Last Dividend	€5.00	2023-05-15
Next Dividend	€0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	27	--
Total Paid Out	€171.20	--
Avg. Dividend % Per Year	0.00%	--
Score	3.1	--
Div. Sustainability Score	8.24
Div.Growth Potential Score	3.98
Div. Directional Score	6.11	--

Next Divdend (Est)
(2024-07-12)

€4.49 Estimate 3.50 %

Dividend Stability

0.28 Very Poor

Dividend Score

3.10

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for XETRA

Symbol	Title	Last dividend	Frequency	Yearly Dividend
PER.DE	Ex Dividend Knight	2023-07-05	Annually	0.00%
BAYN.DE	Ex Dividend Junior	2023-05-02	Annually	0.00%
HNR1.DE	Ex Dividend Junior	2023-05-04	Annually	0.00%
SCT.DE	Ex Dividend Knight	2023-07-27	Annually	0.00%
COK.DE	Ex Dividend Junior	2023-06-15	Annually	0.00%
KRN.DE	Ex Dividend Knight	2023-05-24	Annually	0.00%
185.DE	Ex Dividend Junior	2023-08-07	Quarterly	0.00%
TRVC.DE	Ex Dividend Junior	2023-08-04	Quarterly	0.00%
DYH.DE	Ex Dividend Knight	2023-11-14	Quarterly	0.00%
MUX.DE	Ex Dividend Junior	2023-07-11	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.194	1.500	6.11	9.17	[0 - 0.5]
returnOnAssetsTTM	0.100	1.200	6.66	7.99	[0 - 0.3]
returnOnEquityTTM	0.429	1.500	6.35	9.52	[0.1 - 1]
payoutRatioTTM	1.175	-1.000	10.00	-10.00	[0 - 1]
currentRatioTTM	0.532	0.800	-2.34	-1.871	[1 - 3]
quickRatioTTM	0.281	0.800	-3.06	-2.44	[0.8 - 2.5]
cashRatioTTM	0.0484	1.500	-0.842	-1.263	[0.2 - 2]
debtRatioTTM	0.445	-1.500	2.58	-3.87	[0 - 0.6]
interestCoverageTTM	10.72	1.000	7.14	7.14	[3 - 30]
operatingCashFlowPerShareTTM	27.49	2.00	0.836	1.672	[0 - 30]
freeCashFlowPerShareTTM	21.81	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	1.430	-1.500	4.28	-6.42	[0 - 2.5]
grossProfitMarginTTM	0.666	1.000	2.23	2.23	[0.2 - 0.8]
operatingProfitMarginTTM	0.275	1.000	6.49	6.49	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.278	1.000	9.57	9.57	[0.2 - 2]
assetTurnoverTTM	0.515	0.800	9.90	7.92	[0.5 - 2]
Total Score				8.24

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	38.78	1.000	6.18	0	[1 - 100]
returnOnEquityTTM	0.429	2.50	7.65	9.52	[0.1 - 1.5]
freeCashFlowPerShareTTM	21.81	2.00	2.73	10.00	[0 - 30]
dividendYielPercentageTTM	2.43	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	27.49	2.00	0.836	1.672	[0 - 30]
payoutRatioTTM	1.175	1.500	10.00	-10.00	[0 - 1]
pegRatioTTM	-2.22	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.240	1.000	6.50	0	[0.1 - 0.5]
Total Score				3.98

Coloplast A/S

Coloplast A/S develops, manufactures, and markets medical products. The company is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for people whose intestinal outlet has been rerouted through the abdominal wall, Continence Care products for people suffering from diseases of and damage to the urinary system, Urology Care products for people suffering from diseases of and damage to the kidneys, the urinary system or the male reproductive system and Wound & Skin Care for the treatment of chronic wounds and skin care products for prevention and treatment. The firm supplies products to hospitals, institutions as well as wholesalers and pharmacies.